This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sueoka, E. Articles by Fujiki, H. Search for Related Content PubMed PubMed Citation Articles by Sueoka, E. Articles by Fujiki, H.

Heterogeneous Nuclear Ribonucleoprotein B1 as a New Marker of Early Detection for Human Lung Cancers¹

Saitama Cancer Center Research Institute, Ina, Kitaadachi-gun, Saitama 362-0806, Japan [E. S., Y. G., Y. K., T. K., H. F.], and University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030 [N. S.]

Heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1 is an RNA binding protein that is required for maturation of mRNA precursor. Tockman et al. previously reported that hnRNP A2/B1 with a M_r of 31,000 is overexpressed from the early clinical stage of human lung cancer (M. S. Tockman et al., J. Clin. Oncol., 6: 1685–1693, 1988). However, when hnRNP A2/B1 mRNA and hnRNP B1 mRNA were separately studied, we found unique evidence that hnRNP B1 mRNA, which is a splicing variant of hnRNP A2 mRNA, was more significantly elevated in lung cancer tissues than hnRNP A2/B1 mRNA. Our hnRNP B1-specific polyclonal antibody specifically recognized hnRNP B1 protein as a M_r 37,000 nuclear protein by Western blotting but did not recognize hnRNP A2 protein. Immunohistochemical staining with the hnRNP B1 antibody revealed that hnRNP B1 protein was specifically stained in the nuclei of human cancer cells, and in squamous cell carcinomas in particular, but not in those of normal adjacent lung epithelial cells. We think that hnRNP B1 protein of M_r 37,000, not hnRNP A2, is well qualified as a biomarker for the detection of human lung cancer.

This article has been cited by other articles:

				S. KATSIMPOULA, M. PATRINOU-GEORGOULA, N. MAKRILIA, K. DIMAKOU, A. GUIALIS, D. ORFANIDOU, and K.N. SYRIGOS Overexpression of hnRNPA2/B1 in Bronchoscopic Specimens: A Potential Early Detection Marker in Lung Cancer Anticancer Res, April 1, 2009; 29(4): 1373 - 1382. [Abstract] [Full Text] [PDF]

				Y. He, M. A. Brown, J. A. Rothnagel, N. A. Saunders, and R. Smith Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation J. Cell Sci., July 15, 2005; 118(14): 3173 - 3183. [Abstract] [Full Text] [PDF]

				K. Moran-Jones, L. Wayman, D. D. Kennedy, R. R. Reddel, S. Sara, M. J. Snee, and R. Smith hnRNP A2, a potential ssDNA/RNA molecular adapter at the telomere Nucleic Acids Res., January 19, 2005; 33(2): 486 - 496. [Abstract] [Full Text] [PDF]

				C. Patry, B. Lemieux, R. J. Wellinger, and B. Chabot Targeting heterogeneous nuclear ribonucleoparticule A1 and A2 proteins by RNA interference promotes cell death in transformed but not in normal mouse cell lines Mol. Cancer Ther., October 1, 2004; 3(10): 1193 - 1199. [Abstract] [Full Text] [PDF]

				C. Patry, L. Bouchard, P. Labrecque, D. Gendron, B. Lemieux, J. Toutant, E. Lapointe, R. Wellinger, and B. Chabot Small Interfering RNA-Mediated Reduction in Heterogeneous Nuclear Ribonucleoparticule A1/A2 Proteins Induces Apoptosis in Human Cancer Cells but not in Normal Mortal Cell Lines Cancer Res., November 15, 2003; 63(22): 7679 - 7688. [Abstract] [Full Text] [PDF]

				F B J M Thunnissen Sputum examination for early detection of lung cancer J. Clin. Pathol., November 1, 2003; 56(11): 805 - 810. [Abstract] [Full Text] [PDF]

				J. D. Wulfkuhle, D. C. Sgroi, H. Krutzsch, K. McLean, K. McGarvey, M. Knowlton, S. Chen, H. Shu, A. Sahin, R. Kurek, et al. Proteomics of Human Breast Ductal Carcinoma in Situ Cancer Res., November 15, 2002; 62(22): 6740 - 6749. [Abstract] [Full Text] [PDF]

				A. S. W. Ma, K. Moran-Jones, J. Shan, T. P. Munro, M. J. Snee, K. S. Hoek, and R. Smith Heterogeneous Nuclear Ribonucleoprotein A3, a Novel RNA Trafficking Response Element-binding Protein J. Biol. Chem., May 10, 2002; 277(20): 18010 - 18020. [Abstract] [Full Text] [PDF]

				E. Sueoka, N. Sueoka, Y. Goto, S. Matsuyama, H. Nishimura, M. Sato, S. Fujimura, H. Chiba, and H. Fujiki Heterogeneous Nuclear Ribonucleoprotein B1 as Early Cancer Biomarker for Occult Cancer of Human Lungs and Bronchial Dysplasia Cancer Res., March 1, 2001; 61(5): 1896 - 1902. [Abstract] [Full Text]

				F. R. Hirsch, W. A. Franklin, A. F. Gazdar, and P. A. Bunn Jr. Early Detection of Lung Cancer: Clinical Perspectives of Recent Advances in Biology and Radiology Clin. Cancer Res., January 1, 2001; 7(1): 5 - 22. [Abstract] [Full Text]

				S. A. Brooks and W. F. C. Rigby Characterization of the mRNA ligands bound by the RNA binding protein hnRNP A2 utilizing a novel in vivo technique Nucleic Acids Res., May 15, 2000; 28(10): e49 - e49. [Abstract] [Full Text] [PDF]

				S. C. Gamble, M. J. Dunn, C. H. Wheeler, M. C. Joiner, A. Adu-Poku, and J. E. Arrand Expression of Proteins Coincident with Inducible Radioprotection in Human Lung Epithelial Cells Cancer Res., April 1, 2000; 60(8): 2146 - 2151. [Abstract] [Full Text]

				C. M. Tammemagi, M. S. Tockman, J. L. Mulshine, and S. Piantadosi Correspondence re: M. S. Tockman et al., Prospective Detection of Preclinical Lung Cancer: Results from Two Studies of Heterogeneous Nuclear Ribonucleoprotein A2/B1 Overexpression. Clin. Cancer Res., 3: 2237-2246, 1997. Clin. Cancer Res., April 1, 2000; 6(4): 1601 - 1603. [Full Text]

				M. Mandal, R. Vadlamudi, D. Nguyen, R.-A. Wang, L. Costa, R. Bagheri-Yarmand, J. Mendelsohn, and R. Kumar Growth Factors Regulate Heterogeneous Nuclear Ribonucleoprotein K Expression and Function J. Biol. Chem., March 23, 2001; 276(13): 9699 - 9704. [Abstract] [Full Text] [PDF]

				C. F. Wright, B. W. Oswald, and S. Dellis Vaccinia Virus Late Transcription Is Activated in Vitro by Cellular Heterogeneous Nuclear Ribonucleoproteins J. Biol. Chem., October 26, 2001; 276(44): 40680 - 40686. [Abstract] [Full Text] [PDF]